Fibroblast growth factors 19 and 21 in acute liver damage

Currently there are very few pharmacological options available to treat acute liver injury. Because its natural exposure to noxious stimuli the liver has developed a strong endogenous hepatoprotective capacity. Indeed, experimental evidence exposed a variety of endogenous hepatic and systemic respon...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Transl Med
Hlavní autoři: Shan, Zhao, Alvarez-Sola, Gloria, Uriarte, Iker, Arechederra, María, Fernández-Barrena, Maite G., Berasain, Carmen, Ju, Cynthia, Avila, Matías A.
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2018
Témata:
Review Article on Molecular Hepatology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6046301/
https://ncbi.nlm.nih.gov/pubmed/30069459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2018.05.26
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky